Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
DiaMedica USA Inc.
ClinicalTrials.gov Identifier:
NCT01845064
First received: April 23, 2013
Last updated: December 17, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)